English

Instil Bio, Inc.

EDGAR

TIL Quarterly report (10-Q) · filed 2026-08-13

26 filing records in this dataset, filed from 2021-02-26 to 2026-08-13. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2021 Q4 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Operating cash flow

-42.8 million USD

2021 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -122138000 USD Source
Operating Cash Flow: -79348000 USD Source

Free cash flow

-61.3 million USD

2021 Q4 · USD

Exact inputs and evidence

Operating Cash Flow: -122138000 USD Source
Operating Cash Flow: -79348000 USD Source
Capital Expenditure: 57831000 USD Source
Capital Expenditure: 39367000 USD Source

Cash and cash equivalents: 5.54 million USD 2026-06-30 Source
Exact value

5541000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 6.78 million shares 2026-06-30 Source
Exact value

6781976 shares

Reported share-count change

0.46% · 31.3 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

6750716 shares · 2025-06-30· Source
6781976 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

0 USD

2021-01-01 – 2021-12-31

Exact inputs and evidence

Revenue: 0 USD · 2021-01-01 – 2021-03-31 Source
Revenue: 0 USD · 2021-04-01 – 2021-06-30 Source
Revenue: 0 USD · 2021-07-01 – 2021-09-30 Source
Revenue: 0 USD · 2021-01-01 – 2021-12-31 Source
Revenue: 0 USD · 2021-01-01 – 2021-09-30 Source

Net income

-30.3 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -13587000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -71372000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -63181000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -4204000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -4299000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-23.6 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -29543000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -18986000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -36619000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -29543000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -1337000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -5979000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -1337000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

0 USD

2024-01-01 – 2024-12-31

Exact inputs and evidence

Capital expenditure: 0 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 0 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 0 USD · 2024-01-01 – 2024-03-31 Source
Capital expenditure: 0 USD · 2024-01-01 – 2024-09-30 Source
Capital expenditure: 0 USD · 2024-01-01 – 2024-06-30 Source
Capital expenditure: 0 USD · 2024-01-01 – 2024-12-31 Source
Capital expenditure: 0 USD · 2024-01-01 – 2024-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-13.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2021-12-31
Operating income: 6 of 11 periods available· newest 2025-12-31
Net income: 6 of 11 periods available· newest 2025-12-31
Operating cash flow: 6 of 11 periods available· newest 2025-12-31
Capital expenditure: 5 of 11 periods available· newest 2024-12-31
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 2.76 million

Prior period

−USD 74.14 million

2024-01-01 – 2024-12-31
Current period

−USD 71.37 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-71372000 − -74135000 = 2763000 USD

-74135000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-71372000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Instil Bio, Inc. · 2025-12-31 Instil Bio, Inc. (edgar:1789769) Year-over-year change in Net income: 2763000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -71372000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976926000019/til-20251231.htm#893260 Filing: 000178976926000019 Input fundies:NetIncome: -74135000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976926000019/til-20251231.htm#894035 Filing: 000178976926000019
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 19.08 million

Prior period

−USD 55.7 million

2024-01-01 – 2024-12-31
Current period

−USD 36.62 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-36619000 − -55696000 = 19077000 USD

-55696000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-36619000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Instil Bio, Inc. · 2025-12-31 Instil Bio, Inc. (edgar:1789769) Year-over-year change in Operating cash flow: 19077000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -36619000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976926000019/til-20251231.htm#924628 Filing: 000178976926000019 Input fundies:OperatingCashFlow: -55696000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976926000019/til-20251231.htm#925281 Filing: 000178976926000019
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2021 2021-01-01 – 2021-12-31

Revenue USD 0
Operating costs Derived USD 155.56 million
Operating income −USD 155.56 million
Tax, interest and other Derived USD 1.23 million
Net income −USD 156.79 million

Cash

Operating cash flow −USD 122.14 million
Capital expenditure USD 57.83 million
Free cash flow Derived −USD 179.97 million

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 24,480% of revenue.
2021 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	138000	33782000 Derived	-33644000	4094000 Derived	-37738000	-80432000 Derived	Source 2020-01-01 – 2020-12-31: 138000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -33644000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -37738000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -29616000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 50816000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	0	155560000 Derived	-155560000	1234000 Derived	-156794000	-179969000 Derived	Source 2021-01-01 – 2021-12-31: 0 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -155560000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -156794000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -122138000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 57831000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2021

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	138000	Revenue: 138000 Open source
20212021-12-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-100% 2021

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 138000 Open source
20212021-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 138000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -24,379.7% 2020

Net margin -27,346.4% 2020

Free cash flow margin -58,284.1% 2020

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-24,379.7%	Operating Income: -33644000 Open source Revenue: 138000 Open source
20212021-12-31	Operating margin	Not reported	Operating Income: -155560000 Open source Revenue: 0 Open source
20202020-12-31	Net margin	-27,346.4%	Net Income: -37738000 Open source Revenue: 138000 Open source
20212021-12-31	Net margin	Not reported	Net Income: -156794000 Open source Revenue: 0 Open source
20202020-12-31	Free cash flow margin	-58,284.1%	Revenue: 138000 Open source Operating Cash Flow: -29616000 Open source Capital Expenditure: 50816000 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -122138000 Open source Capital Expenditure: 57831000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -122.1M 2021

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	-29616000	Operating Cash Flow: -29616000 Open source
20212021-12-31	Operating cash flow	-122138000	Operating Cash Flow: -122138000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -180M 2021

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	-80432000	Operating Cash Flow: -29616000 Open source Capital Expenditure: 50816000 Open source
20212021-12-31	Free cash flow	-179969000	Operating Cash Flow: -122138000 Open source Capital Expenditure: 57831000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

9% 2021

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	8.4%	Total Liabilities: 26645000 Open source Total Assets: 319012000 Open source
20212021-12-31	Liabilities / assets	9%	Total Liabilities: 54784000 Open source Total Assets: 609983000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

11.22× 2021

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	18.53×	Current Assets: 246138000 Open source Current Liabilities: 13281000 Open source
20212021-12-31	Current assets / current liabilities	11.22×	Current Assets: 464020000 Open source Current Liabilities: 41358000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 37.74 million Exact value Exact value: -37738000 USD 2020-01-01 – 2020-12-31: -37738000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Instil Bio, Inc. · 2020-12-31 Instil Bio, Inc. (edgar:1789769) Net Income: -37738000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -37738000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976922000008/til-20211231.htm#1252762 Filing: 000178976922000008 The citation records this snapshot. The page link may show a newer release later.	−USD 29.62 million Exact value Exact value: -29616000 USD 2020-01-01 – 2020-12-31: -29616000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Instil Bio, Inc. · 2020-12-31 Instil Bio, Inc. (edgar:1789769) Operating Cash Flow: -29616000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -29616000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976922000008/til-20211231.htm#1277821 Filing: 000178976922000008 The citation records this snapshot. The page link may show a newer release later.	USD 50.82 million Exact value Exact value: 50816000 USD 2020-01-01 – 2020-12-31: 50816000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Instil Bio, Inc. · 2020-12-31 Instil Bio, Inc. (edgar:1789769) Capital Expenditure: 50816000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 50816000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976922000008/til-20211231.htm#1285030 Filing: 000178976922000008 The citation records this snapshot. The page link may show a newer release later.	−USD 80.43 million Calculation and evidence -29616000 − 50816000 USD Exact free cash flow: -80432000 USD 2020-01-01 – 2020-12-31: -29616000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 50816000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Instil Bio, Inc. · 2020-12-31 Instil Bio, Inc. (edgar:1789769) Free cash flow: -80432000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29616000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976922000008/til-20211231.htm#1277821 Filing: 000178976922000008 Input fundies:CapitalExpenditure: 50816000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976922000008/til-20211231.htm#1285030 Filing: 000178976922000008 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 156.79 million Exact value Exact value: -156794000 USD 2021-01-01 – 2021-12-31: -156794000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Instil Bio, Inc. · 2021-12-31 Instil Bio, Inc. (edgar:1789769) Net Income: -156794000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -156794000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976923000035/til-20221231.htm#1127617 Filing: 000178976923000035 The citation records this snapshot. The page link may show a newer release later.	−USD 122.14 million Exact value Exact value: -122138000 USD 2021-01-01 – 2021-12-31: -122138000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Instil Bio, Inc. · 2021-12-31 Instil Bio, Inc. (edgar:1789769) Operating Cash Flow: -122138000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -122138000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976923000035/til-20221231.htm#1154346 Filing: 000178976923000035 The citation records this snapshot. The page link may show a newer release later.	USD 57.83 million Exact value Exact value: 57831000 USD 2021-01-01 – 2021-12-31: 57831000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Instil Bio, Inc. · 2021-12-31 Instil Bio, Inc. (edgar:1789769) Capital Expenditure: 57831000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 57831000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976923000035/til-20221231.htm#1159494 Filing: 000178976923000035 The citation records this snapshot. The page link may show a newer release later.	−USD 179.97 million Calculation and evidence -122138000 − 57831000 USD Exact free cash flow: -179969000 USD 2021-01-01 – 2021-12-31: -122138000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 57831000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Instil Bio, Inc. · 2021-12-31 Instil Bio, Inc. (edgar:1789769) Free cash flow: -179969000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -122138000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976923000035/til-20221231.htm#1154346 Filing: 000178976923000035 Input fundies:CapitalExpenditure: 57831000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976923000035/til-20221231.htm#1159494 Filing: 000178976923000035 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 223.18 million Exact value Exact value: -223177000 USD 2022-01-01 – 2022-12-31: -223177000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Instil Bio, Inc. · 2022-12-31 Instil Bio, Inc. (edgar:1789769) Net Income: -223177000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -223177000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976924000036/til-20231231.htm#1034188 Filing: 000178976924000036 The citation records this snapshot. The page link may show a newer release later.	−USD 180.16 million Exact value Exact value: -180164000 USD 2022-01-01 – 2022-12-31: -180164000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Instil Bio, Inc. · 2022-12-31 Instil Bio, Inc. (edgar:1789769) Operating Cash Flow: -180164000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -180164000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976924000036/til-20231231.htm#1064459 Filing: 000178976924000036 The citation records this snapshot. The page link may show a newer release later.	USD 84.59 million Exact value Exact value: 84589000 USD 2022-01-01 – 2022-12-31: 84589000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Instil Bio, Inc. · 2022-12-31 Instil Bio, Inc. (edgar:1789769) Capital Expenditure: 84589000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 84589000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976924000036/til-20231231.htm#1069263 Filing: 000178976924000036 The citation records this snapshot. The page link may show a newer release later.	−USD 264.75 million Calculation and evidence -180164000 − 84589000 USD Exact free cash flow: -264753000 USD 2022-01-01 – 2022-12-31: -180164000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 84589000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Instil Bio, Inc. · 2022-12-31 Instil Bio, Inc. (edgar:1789769) Free cash flow: -264753000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -180164000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976924000036/til-20231231.htm#1064459 Filing: 000178976924000036 Input fundies:CapitalExpenditure: 84589000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976924000036/til-20231231.htm#1069263 Filing: 000178976924000036 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 156.09 million Exact value Exact value: -156087000 USD 2023-01-01 – 2023-12-31: -156087000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Instil Bio, Inc. · 2023-12-31 Instil Bio, Inc. (edgar:1789769) Net Income: -156087000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -156087000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976925000017/til-20241231.htm#988126 Filing: 000178976925000017 The citation records this snapshot. The page link may show a newer release later.	−USD 82.03 million Exact value Exact value: -82029000 USD 2023-01-01 – 2023-12-31: -82029000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Instil Bio, Inc. · 2023-12-31 Instil Bio, Inc. (edgar:1789769) Operating Cash Flow: -82029000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -82029000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976925000017/til-20241231.htm#1017081 Filing: 000178976925000017 The citation records this snapshot. The page link may show a newer release later.	USD 20.66 million Exact value Exact value: 20663000 USD 2023-01-01 – 2023-12-31: 20663000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Instil Bio, Inc. · 2023-12-31 Instil Bio, Inc. (edgar:1789769) Capital Expenditure: 20663000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 20663000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976925000017/til-20241231.htm#1021956 Filing: 000178976925000017 The citation records this snapshot. The page link may show a newer release later.	−USD 102.69 million Calculation and evidence -82029000 − 20663000 USD Exact free cash flow: -102692000 USD 2023-01-01 – 2023-12-31: -82029000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 20663000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Instil Bio, Inc. · 2023-12-31 Instil Bio, Inc. (edgar:1789769) Free cash flow: -102692000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -82029000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976925000017/til-20241231.htm#1017081 Filing: 000178976925000017 Input fundies:CapitalExpenditure: 20663000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976925000017/til-20241231.htm#1021956 Filing: 000178976925000017 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 74.14 million Exact value Exact value: -74135000 USD 2024-01-01 – 2024-12-31: -74135000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Instil Bio, Inc. · 2024-12-31 Instil Bio, Inc. (edgar:1789769) Net Income: -74135000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -74135000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976926000019/til-20251231.htm#894035 Filing: 000178976926000019 The citation records this snapshot. The page link may show a newer release later.	−USD 55.7 million Exact value Exact value: -55696000 USD 2024-01-01 – 2024-12-31: -55696000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Instil Bio, Inc. · 2024-12-31 Instil Bio, Inc. (edgar:1789769) Operating Cash Flow: -55696000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -55696000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976926000019/til-20251231.htm#925281 Filing: 000178976926000019 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2024-01-01 – 2024-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Instil Bio, Inc. · 2024-12-31 Instil Bio, Inc. (edgar:1789769) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976925000017/til-20241231.htm#1021358 Filing: 000178976925000017 The citation records this snapshot. The page link may show a newer release later.	−USD 55.7 million Calculation and evidence -55696000 − 0 USD Exact free cash flow: -55696000 USD 2024-01-01 – 2024-12-31: -55696000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Instil Bio, Inc. · 2024-12-31 Instil Bio, Inc. (edgar:1789769) Free cash flow: -55696000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -55696000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976926000019/til-20251231.htm#925281 Filing: 000178976926000019 Input fundies:CapitalExpenditure: 0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976925000017/til-20241231.htm#1021358 Filing: 000178976925000017 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 71.37 million Exact value Exact value: -71372000 USD 2025-01-01 – 2025-12-31: -71372000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Instil Bio, Inc. · 2025-12-31 Instil Bio, Inc. (edgar:1789769) Net Income: -71372000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -71372000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976926000019/til-20251231.htm#893260 Filing: 000178976926000019 The citation records this snapshot. The page link may show a newer release later.	−USD 36.62 million Exact value Exact value: -36619000 USD 2025-01-01 – 2025-12-31: -36619000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Instil Bio, Inc. · 2025-12-31 Instil Bio, Inc. (edgar:1789769) Operating Cash Flow: -36619000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T12:31:09Z Snapshot: 019a84084feddf939844379650e79e2eae1248e25b8e10ef500a88bfd3fa67a7 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1789769/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36619000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1789769/000178976926000019/til-20251231.htm#924628 Filing: 000178976926000019 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

26 filings · 1,510 latest values · 1,510 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001789769, 1789769, TIL, edgar:1789769

Also known as Instil Bio, Inc.

Instil Bio, Inc.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2021 2021-01-01 – 2021-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation